The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease
Open accessAbstract
To validate the provisional findings of a number of smaller studies and explore additional determinants of characteristic diagnostic investigation results across the entire clinical spectrum of sporadic Creutzfeldt-Jakob disease (CJD), an international collaborative study was undertaken comprising 2451 pathologically confirmed (definite) patients. We assessed the influence of age at disease onset, illness duration, prion protein gene (PRNP) codon 129 polymorphism (either methionine or valine) and molecular sub-type on the diagnostic sensitivity of EEG, cerebral MRI and the CSF 14-3-3 immunoassay. For EEG and CSF 14-3-3 protein detection, we also assessed the influence of the time point in a patient's illness at which the investigation was performed on the likelihood of a typical or positive result. Analysis included a large subset of patients (n = 743) in whom molecular sub-typing had been performed using a combination of the PRNP codon 129 polymorphism and the form of protease resistant prion protein [type 1 or 2 according to Parchi et al. (Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999; 46: 224-233.)] present in the brain. Findings for the whole group paralleled the subset with molecular sub-typing data available, showing that age at disease onset and disease duration were independent determinants of typical changes on EEG, while illness duration significantly influenced positive CSF 14-3-3 protein detection; changes on brain MRI were not influenced by either of these clinical parameters, but overall, imaging data were less complete and consequently conclusions are more tentative. In addition to age at disease onset and illness duration, molecular sub-type was re-affirmed as an important independent determinant of investigation results. In multivariate analyses that included molecular sub-type, time point of the investigation during a patient's illness was found not to influence the occurrence of a typical or positive EEG or CSF 14-3-3 protein result. A typical EEG was most often seen in MM1 patients and was significantly less likely in the MV1, MV2 and VV2 sub-types, whereas VV2 patients had an increased likelihood of a typical brain MRI. Overall, the CSF 14-3-3 immunoassay was the most frequently positive investigation (88.1%) but performed significantly less well in the very uncommon MV2 and MM2 sub-types. Our findings confirm a number of determinants of principal investigation results in sporadic CJD and underscore the importance of recognizing these pre-test limitations before accepting the diagnosis excluded or confirmed. Combinations of investigations offer the best chance of detection, especially for the less common molecular sub-types such as MV2 and MM2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease
Zerr, I., Pocchiari, M., Collins, S., Brandel, J. P., de Pedro Cuesta, J., Knight, R. S. G., Bernheimer, H., Cardone, F., Delasnerie-Lauprêtre, N., Cuadrado Corrales, N., et al. (2000) · Neurology · doi:10.1212/wnl.55.6.811 · Cited by 481
Self-citationMortality from Creutzfeldt–Jakob disease and related disorders in Europe, Australia, and Canada
Ladogana, A., Puopolo, M., Croes, E. A., Budka, H., Jarius, C., Collins, S., Klug, G. M., Sutcliffe, T., Giulivi, A., Alperovitch, A., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000160117.56690.b2 · Cited by 387
Self-citationMolecular classification of sporadic Creutzfeldt–Jakob disease
Hill, A. F., Joiner, S., Wadsworth, J. D. F., Sidle, K. C. L., Bell, J. E., Budka, H., Ironside, J. W., & Collinge, J. (2003) · Brain · doi:10.1093/brain/awg125 · Cited by 367
Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt–Jakob disease
Shiga, Y., Miyazawa, K., Sato, S., Fukushima, R., Shibuya, S., Sato, Y., Konno, H., Doh-ura, K., Mugikura, S., Tamura, H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000134555.59460.5d · Cited by 361
Transmissible spongiform encephalopathies
Collins, S. J., Lawson, V. A., & Masters, C. L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15171-9 · Cited by 339
Self-citationPocchiari, M. (2004) · Brain · doi:10.1093/brain/awh249 · Cited by 302
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt–Jakob disease
Otto, M., Wiltfang, J., Cepek, L., Neumann, M., Mollenhauer, B., Steinacker, P., Ciesielczyk, B., Schulz–Schaeffer, W., Kretzschmar, H. A., & Poser, S. (2002) · Neurology · doi:10.1212/wnl.58.2.192 · Cited by 289
Accuracy and Reliability of Periodic Sharp Wave Complexes in Creutzfeldt-Jakob Disease
Steinhoff, B. J., Racker, S., Herrendorf, G., Poser, S., Grosche, S., Zerr, I., Kretzschmar, H., & Weber, T. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020074017 · Cited by 281
Magnetic Resonance Imaging in the Clinical Diagnosis of Creutzfeldt-Jakob Disease
Schröter, A., Zerr, I., Henkel, K., Tschampa, H. J., Finkenstaedt, M., & Poser, S. (2000) · Archives of Neurology · doi:10.1001/archneur.57.12.1751 · Cited by 255
Diagnostic value of periodic complexes in Creutzfeldt–Jakob disease
Steinhoff, B. J., Zerr, I., Glatting, M., Schulz‐Schaeffer, W., Poser, S., & Kretzschmar, H. A. (2004) · Annals of Neurology · doi:10.1002/ana.20261 · Cited by 240
Sporadic Creutzfeldt-Jakob disease: Co-occurrence of different types of PrP Sc in the same brain
Puoti, G., Giaccone, G., Rossi, G., Canciani, B., Bugiani, O., & Tagliavini, F. (1999) · Neurology · doi:10.1212/wnl.53.9.2173 · Cited by 198
Current clinical diagnosis in Creutzfeldt-Jakob disease: Identification of uncommon variants
Zerr, I., Schulz-Schaeffer, W. J., Giese, A., Bodemer, M., Schröter, A., Henkel, K., Tschampa, H. J., Windl, O., Pfahlberg, A., Steinhoff, B. J., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200009)48:3<323::aid-ana6>3.0.co;2-5 · Cited by 189
MRI of Creutzfeldt–Jakob Disease: Imaging Features and Recommended MRI Protocol
Collie, D. A., Sellar, R. J., Zeidler, M., Colchester, A. C. F., Knight, R., & Will, R. G. (2001) · Clinical Radiology · doi:10.1053/crad.2001.0771 · Cited by 180
Head, M. W., Bunn, T. J. R., Bishop, M., McLoughlin, V., Lowrie, S., McKimmie, C. S., Williams, M. C., McCardle, L., MacKenzie, J. M., Knight, R., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20127 · Cited by 151
Korth, C., Kaneko, K., Groth, D., Heye, N., Telling, G. C., Mastrianni, J. A., Parchi, P., Gambetti, P. L., Will, R. G., Ironside, J. W., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2627989100 · Cited by 134
Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease
Castellani, R. J., Colucci, M. E. W., Xie, Z.-L., Zou, W., Li, C., Parchi, P., Capellari, S., Pastore, M., Rahbar, M. H., Chen, S. G., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000135153.96325.3b · Cited by 126
MRI in the diagnosis of sporadic Creutzfeldt–Jakob disease: a study on inter-observer agreement
Tschampa, H. J., Kallenberg, K., Urbach, H., Meißner, B., Nicolay, C., Kretzschmar, H. A., Knauth, M., & Zerr, I. (2005) · Brain · doi:10.1093/brain/awh575 · Cited by 122
Sporadic Creutzfeldt-Jakob disease
Meißner, B., Köhler, K., Körtner, K., Bartl, M., Jastrow, U., Mollenhauer, B., Schröter, A., Finkenstaedt, M., Windl, O., Poser, S., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000136225.80445.c9 · Cited by 117
High incidence of genetic human transmissible spongiform encephalopathies in Italy
Ladogana, A., Puopolo, M., Poleggi, A., Almonti, S., Mellina, V., Equestre, M., & Pocchiari, M. (2005) · Neurology · doi:10.1212/01.wnl.0000160118.26865.11 · Cited by 81
Novel Prion Protein Gene Mutation in an Octogenarian With Creutzfeldt-Jakob Disease
Collins, S. J., Boyd, A., Fletcher, A., Byron, K. A., Harper, C. C., McLean, C., & Masters, C. L. (2000) · Archives of Neurology · doi:10.1001/archneur.57.7.1058 · Cited by 47
Self-citationDall’Asta, C., Barbetta, L., Libé, R., Passini, E., & Ambrosi, B. (2002) · Hormone Research in Paediatrics · doi:10.1159/000058381 · Cited by 38
Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2<224::aid-ana12>3.0.co;2-w
Cited by
Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease
Zerr, I., Kallenberg, K., Summers, D. M., Romero, C., Taratuto, A., Heinemann, U., Breithaupt, M., Varges, D., Meissner, B., Ladogana, A., et al. (2009) · Brain · doi:10.1093/brain/awp191 · Cited by 916
Self-citationDiffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias
Vitali, P., Maccagnano, E., Caverzasi, E., Henry, R. G., Haman, A., Torres-Chae, C., Johnson, D. Y., Miller, B. L., & Geschwind, M. D. (2011) · Neurology · doi:10.1212/wnl.0b013e31821a4439 · Cited by 399
Sporadic human prion diseases: molecular insights and diagnosis
Puoti, G., Bizzi, A., Forloni, G., Safar, J. G., Tagliavini, F., & Gambetti, P. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70063-7 · Cited by 365
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease
Hermann, P., Appleby, B., Brandel, J.-P., Caughey, B., Collins, S., Geschwind, M. D., Green, A., Haïk, S., Kovacs, G. G., Ladogana, A., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30477-4 · Cited by 361
Self-citationGeschwind, M. D., Shu, H., Haman, A., Sejvar, J. J., & Miller, B. L. (2008) · Annals of Neurology · doi:10.1002/ana.21430 · Cited by 323
Metadata
- Authors
- Collins, S. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-01
- Volume
- 129
- Issue
- 9
- Pages
- 2278-2287
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2111396693
- Cited by
- 338
- References
- 22
- FWCI
- 7.37
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.